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Abstract. Cortisol, corticosterone and aldosterone activate full-length glucocorticoid 
receptor (GR) from elephant shark, a cartilaginous fish belonging to the oldest group of 
jawed vertebrates.  Activation by aldosterone a mineralocorticoid, indicates partial 
divergence of elephant shark GR from the MR.  Progesterone activates elephant shark 
MR, but not elephant shark GR.  Progesterone inhibits steroid binding to elephant 
shark GR, but not to human GR.  Deletion of the N-terminal domain (NTD) from 
elephant shark GR (Truncated GR) reduced the response to corticosteroids, while 
truncated and full-length elephant shark MR had similar responses to corticosteroids.  
Chimeras of elephant shark GR NTD fused to MR DBD+LBD had increased activation 
by corticosteroids and progesterone compared to full-length elephant shark MR.  
Elephant shark MR NTD fused to GR DBD+LBD had similar activation as full-length 
elephant shark MR, indicating that activation of human GR by the NTD evolved early 
in GR divergence from the MR. 
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Introduction 
Glucocorticoids, such as cortisol and corticosterone, have diverse physiological 
activities in humans and other terrestrial vertebrates, including regulating glucose 
metabolism, cognition, immunity and the response to stress (1-5).  The physiological 
actions of glucocorticoids are mediated by the glucocorticoid receptor (GR), which 
belongs to the nuclear receptor family, a diverse group of transcription factors that also 
contains receptors for mineralocorticoids (MR), progestins (PR) androgens (AR) and 
estrogens (ER) (6-8). 
The GR is closely related to the MR (9); phylogenetic analysis indicates that the 
GR and MR evolved from a corticoid receptor (CR) that evolved in a jawless vertebrate 
that was an ancestor of modern lamprey and hagfish (7, 10-13).  Distinct orthologs of 
human GR and human MR first appear in cartilaginous fishes, the oldest group of extant 
jawed vertebrates (gnathostomes) that diverged from bony vertebrates about 450 million 
years ago (14).  Since the emergence of the GR and MR in cartilaginous fishes, these 
steroid receptors have diverged to respond to different corticosteroids.  For example, 
human MR is activated by aldosterone, the physiological mineralocorticoid in humans, 
at a concentration at least ten-fold lower than by cortisol (15-19).  However, 
aldosterone has little activity for human GR, which is activated by cortisol (Figure 1) 
(10, 13, 15, 17, 20). 
The multi-domain structure of the GR is important in regulating steroid 
activation of the GR.  Like other steroid receptors, the GR consists of an N-terminal 
domain (NTD) (domains A and B), a central DNA-binding domain (DBD) (domain C), 
a hinge domain (D) and a C-terminal ligand-binding domain (LBD) (domain E) (5, 8, 
17, 21, 22) (Figure 2).  Allosteric interactions between the NTD and LBD increase 
corticosteroid activation of GR in humans, other terrestrial vertebrates (17, 22-28) and 
ray-finned fish (22, 29).  For example, neither cortisol nor corticosterone activate 
truncated human GR in which the NTD is deleted (17, 22).  It is not known when the 
strong dependence of vertebrate GR on the NTD for activation of gene transcription 
evolved. 
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Fig. 1. Structures of Corticosteroids and Progesterone.  Cortisol and corticosterone 
are physiological glucocorticoids in terrestrial vertebrates and ray-finned fish (7, 10, 30).  
Aldosterone, 11-deoxycorticosterone are physiological mineralocorticoids (10, 13, 31, 
32).  Progesterone is female reproductive steroid that also is important in male 
physiology (33, 34). 
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Fig.2. Comparison of domains in elephant shark GR with vertebrate GRs and 
MRs.  GRs from elephant shark, zebrafish, X. laevis, chicken and humans and MRs 
from elephant shark, humans and zebrafish are compared.  The functional A/B domain 
to E domains are schematically represented with the numbers of amino acid residues 
and the percentage of amino acid identity depicted. 
 
To investigate corticosteroid signaling via the GR, in the light of the evolution 
(35), we decided to study activation of full-length and truncated elephant shark 
(Callorhinchus milii) GR by a panel of corticosteroids, which were used in a previous 
study of elephant shark MR (36).  Elephant shark is an excellent system for 
evolutionary studies because in addition to the key phylogenetic position of elephant 
shark in vertebrate evolution, as a precursor for ray-finned fish and terrestrial 
vertebrates, genomic analyses reveal that elephant shark genes are evolving slowly, 
which makes their genes windows into the past (14).  Thus, characterization of steroid 
activation of elephant shark GR permits analyses relevant to early events in the 
divergence of the GR and its MR paralog. 
Two questions arise regarding the evolution of glucocorticoid activation of the 
GR.  First, what were the active glucocorticoids early in the evolutionary divergence of 
the GR from its common ancestor with the MR?  That is, what is the response of 
elephant shark GR to physiological glucocorticoids (cortisol, corticosterone) and 
mineralocorticoids (aldosterone, 11-deoxycorticosterone), as well as progesterone, all of 
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which activate elephant shark MR (36)?  Interestingly, aldosterone, which is not found 
in cartilaginous fishes (11, 37), has a half maximal response (EC50) of 11 nM for 
truncated skate GR in which the NTD is deleted (37).  The EC50 of 11 nM of 
aldosterone for skate GR is lower than the EC50s of 139 nM and 58 nM, respectively, 
for cortisol and corticosterone for skate GR (37).  However, because an analysis of 
corticosteroid activation of a full-length cartilaginous fish GR has not been reported, the 
identity of physiological glucocorticoids in cartilaginous fish is not known. 
The absence of data on steroid activation of a full-length cartilaginous fish GR, 
raises a second question: What is the role of the NTD in corticosteroid activation of the 
elephant shark GR, and how does it compare to the role of the NTD in human GR (17, 
22, 24) and elephant shark MR? 
As reported here, we find that full-length elephant shark GR is activated by 
cortisol and corticosterone, which activate human GR (25).  Unexpectedly, aldosterone 
and 11-deoxycorticosterone, two mineralocorticoids, also activated elephant shark GR.  
These two mineralocorticoids have little activity for human GR (15, 19, 25), which is 
selective for cortisol and corticosterone (25).  Elephant shark GR is not activated by 
either progesterone or 19norprogesterone, in contrast to elephant shark MR, which also 
is activated by cortisol and corticosterone (36).  However, we find that progesterone 
and 19norprogesterone inhibit corticosterone activation of elephant GR, while neither 
progestin inhibits cortisol activation of human GR. 
We find that activation by corticosteroids of truncated elephant shark GR, in 
which the NTD is deleted, was less than 10% of that of full-length GR, in contrast to 
truncated elephant shark MR, in which deletion of the NTD did not have a major effect 
on corticosteroid activation (36).  To investigate specificity of the NTD for activation 
of the GR and MR, we studied chimeras of elephant shark GR and MR in which the GR 
NTD was fused to elephant shark MR DBD-LBD and the MR NTD was fused to GR 
DBD-LBD.  Activation by cortisol and corticosterone of elephant shark GR NTD 
fused to MR DBD-LBD increased by over 10-fold, compared to full length elephant 
shark MR.  Interestingly, the chimera of GR NTD MR DBD-LBD had increased 
activation by progesterone and 19norprogestrone.  In contrast, corticosteroid activation 
of the MR NTD fused to GR DBD-LBD was reduced by over 90%.  These data 
indicate allosteric regulation by the NTD in elephant shark GR evolved after the 
divergence of the GR from its common ancestor with the MR. 
 
Results 
Functional domains on elephant shark GR and other vertebrate GRs. 
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In Figure 2, we compare the functional domains of elephant shark GR to 
domains in selected vertebrate GRs (human, chicken, Xenopus, zebrafish) and MRs 
(human, zebrafish and elephant shark).  Elephant shark GR and human GR have 98% 
and 67% identity in DBD and LBD, respectively.  The DBD and LBD in elephant 
shark GR is conserved in other GRs.  The A, B and D domains of elephant shark GR 
are much less conserved with other GRs.  These GRs and elephant shark GR have over 
95% and 65% identity in the DBD and LBD, respectively.  Elephant shark GR and mR 
have good conservation in their D and E domains, with 95% and 61% identity, 
respectively. 
 
Effect of corticosteroids and progesterone on transcriptional activation of 
full-length elephant shark GR and MR. 
Activation of full-length elephant shark GR by 10-8 M cortisol, corticosterone, 
11-deoxycorticosterone, aldosterone, progesterone and 19norProgesterone is shown in 
Figure 3A.  For comparison activation of elephant shark MR by these steroids is 
shown in Figure 3B.  Cortisol, corticosterone, 11-deoxycorticosterone, and aldosterone 
activated full-length elephant shark GR (Figure 3A) and MR (Figure 3B).  However, 
activation of full-length elephant shark GR by corticosteroids at 10-8 M was over 
10-fold higher than for full-length elephant shark MR.  Interestingly, neither 
progesterone nor 19norProgesterone activated elephant shark GR, but these steroids did 
activate elephant shark MR, as previously reported (36). 
 
Effect of corticosteroids and progesterone on transcriptional activation of 
truncated elephant shark GR and MR. 
We investigated the role of the NTD in the response of elephant shark GR and 
MR to corticosteroids and progestins at 10-8 M, by constructing truncated elephant shark 
GR and MR, in which the NTD was deleted (Figure 3C, D).  Figure 3C shows that 
activation of truncated elephant shark GR by 10-8 M corticosterone decreased by over 
90%, compared to full-length elephant shark GR (Figure 3A), and there was no 
significant activation of truncated GR by 10-8 M of either cortisol or 
11-deoxycorticosterone, both of which activated full-length GR.  Progesterone did not 
activate truncated elephant shark GR.  In contrast, 10-8 M corticosteroids and 
progesterone had similar levels of activation of truncated elephant shark MR (Figure 
3D) and full-length MR (Figure3B), indicating that there is a major difference in the 
role of the NTD in transcriptional activation of elephant shark GR and MR. 
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Fig. 3. Ligand specificity of full-length and truncated elephant shark GR and MR. 
Plasmids for full-length elephant shark GR or MR or truncated elephant GR or MR, 
containing the DBD (C domain), D domain and LBD (E domain), were expressed in 
HEK293 cells with an MMTV-luciferase reporter.  Transfected cells were treated with 
either 10 nM cortisol, corticosterone, aldosterone, 11-deoxycorticosterone, progesterone, 
19norProgesterone or vehicle alone (DMSO).  Results are expressed as means ± SEM, 
n=3.  Y-axis indicates fold-activation compared to the activity of control vector with 
vehicle (DMSO) alone as 1.  A. Full-length GR.  B. Full-length MR.  C. Truncated 
GR.  D. Truncated MR. 
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Fig. 4. Concentration-dependent transcriptional activation by corticosteroids and 
progesterone of full length and truncated elephant shark GR and MR.  Plasmids 
for full-length elephant shark GR or MR or truncated elephant GR or MR, were 
expressed in HEK293 cells with an MMTV-luciferase reporter.  Cells were treated with 
increasing concentrations of either cortisol, corticosterone, aldosterone, 
11-deoxycorticosterone, progesterone, 19norProgesterone or vehicle alone (DMSO).  
Results are expressed as means ± SEM, n=3.  Y-axis indicates fold-activation 
compared to the activity of control vector with vehicle (DMSO) alone as 1.  A. 
Full-length GR.  B. Full-length MR.  C. Truncated GR.  D. Truncated MR. 
 
Next, we determined the concentration dependence of transcriptional activation 
by these corticosteroids of full-length and truncated elephant shark GR (Figure 4A, B) 
and MR (Figure 4C, D).  This data was used to calculate EC50 values for steroid 
activation of full-length and truncated elephant shark GR and MR, which are shown in 
Table 1.  Corticosterone and cortisol, two physiological glucocorticoids in mammals, 
had EC50s of 7.9 nM and 35 nM, respectively, for full-length elephant shark GR.  For 
comparison, the EC50s of corticosterone and cortisol are 0.61 nM and 1.6 nM, 
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respectively, for full-length elephant shark MR (Table 1) (36).  However, aldosterone 
and 11-deoxycorticosterone, two physiological mineralocorticoids in mammals, had 
EC50s of 24 nM and 28 nM respectively, for elephant shark GR, indicating that 
elephant shark GR retains some properties of its MR paralog.  For comparison, the 
EC50s of aldosterone and 11-deoxycorticosterone are 0.14 nM and 0.1 nM, respectively, 
for full-length elephant shark MR (Table 1) (36).  EC50s of corticosterone, cortisol and 
aldosterone for truncated GR were 9.4 nM, 66 nM and 65 nM respectively, while all 
four corticosteroids, progesterone and 19norProgesterone activated truncated MR with 
EC50s that were similar or lower than that of full-length MR. 
 
 
 
The dependence of the level of cortisol activation on the NTD in elephant shark 
GR is similar to that of human GR, in which deletion of the NTD reduces cortisol 
activation by over 90% (17, 24).  These results indicate that allosteric signaling 
between the NTD and DBD-LBD in elephant shark GR is critical for its response to 
corticosteroids, in contrast to elephant shark MR, in which truncated MR and full-length 
elephant shark MR have similar levels of activation by corticosteroids and progesterone. 
 
Progesterone binds to, but does not activate, full-length elephant shark GR. 
Neither progesterone nor19norProgesterone activated transcription by elephant 
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shark GR (Figure 3A), although these steroids are transcriptional activators of elephant 
shark MR (Figure 3B) (36).  However, unexpectedly, we find that progesterone and 
19norProgesterone inhibit activation of elephant shark GR by 10 nM corticosterone 
(Figure 5A) indicating that elephant shark GR recognizes progesterone.  A parallel 
study showed that neither progesterone nor 19norProgesterone inhibited activation of 
human GR by 10 nM cortisol (Figure 5B). 
 
Fig. 5. Progesterone inhibits corticosterone activation of full-length elephant shark 
GR.  Plasmids encoding full length elephant GR or human GR were expressed in 
HEK293 cells.  Cells with elephant shark GR and human GR were treated with 10 nM 
corticosterone and cortisol respectively and increasing concentrations of either 
progesterone, 19norProgesterone or estrone.  Y-axis indicates fold-activation compared 
to the activity of control vector with vehicle (DMSO) alone as 1. 
A. Elephant shark GR.  B. Human GR. 
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Corticosteroid activation of chimeras in which the NTD is swapped between 
elephant shark GR and MR. 
To investigate further the evolution of transcriptional activity of the NTD in 
elephant shark GR and MR, we studied corticosteroid activation of elephant shark GR 
and MR chimeras, in which the GR NTD was fused to MR DBD-LBD and the MR 
NTD was fused to GR DBD-LBD (Figure 6).  The NTDs of the GR and MR had 
dominant effects on transcription of the DBD-LBD in each chimera (Figure 6, Table 1).  
Thus, in the GR NTD-MR DBD-LBD chimera (GR NTD fused to MR DBD-LBD), 
cortisol and corticosterone increased activation by over 30-fold, compared to full length 
elephant shark MR (Figures 3B, 4B and 6B).  Moreover, the GR NTD-MR DBD-LBD 
chimera also had a higher level of activation in the presence of progesterone and 
19norProgestrone.  In addition, the EC50s for corticosteroids and progestin were lower 
in the GR NTD-MR DBD-LBD chimera indicating that the NTD affects the affinity of 
steroids for the chimera, as well as the level of transcriptional activation (Table 1). 
In contrast, the MR NTD reduced corticosteroid activation of the MR NTD-GR 
DBD-LBD chimera by over 90% compared to full-length GR (Figures 3A, 4A and 6A).  
Moreover, the EC50 for cortisol increased over 2-fold, and an EC50 for 
11-deoxycorticosterone was too low to be calculated (Table 1).  These data indicate 
that increased activation of the GR by the NTD in elephant shark GR evolved after it 
diverged from the MR. 
 
Fig. 6. Concentration-dependent transcriptional activation by corticosteroids of 
chimeras of GR and MR.  Plasmids for chimeric GR or MR were expressed in 
HEK293 cells with an MMTV-luciferase reporter.  Cells were treated with increasing 
concentrations of either cortisol, corticosterone, aldosterone, 11-deoxycorticosterone, 
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progesterone, 19norProgesterone or vehicle alone (DMSO).  Results are expressed as 
means ± SEM, n=3.  Y-axis indicates fold-activation compared to the activity of 
control vector with vehicle (DMSO) alone as 1.  A. Chimera of MR-A/B fused to 
GR-DBD-LBD.  B. Chimera of GR-A/B fused to MR-DBD-LBD. 
 
Discussion 
Sequence analysis revealed that the MR and GR are kin (9).  A distinct GR and 
MR, first appear in cartilaginous fish, which occupy a key position at an ancestral node 
from which ray-finned fish and terrestrial vertebrates diverged (14, 38).  To investigate 
early events in the evolution of steroid specificity for the GR during its divergence from 
the MR, we studied corticosteroid activation of full-length elephant shark GR, which we 
compared to similar experiments with elephant shark MR (36).  Because the NTD has 
a strong activation function for human GR (17, 24), we also studied elephant shark GR, 
in which the NTD was deleted.  After finding that corticosterone activation of this 
truncated GR declined by over 90% from the activity of full-length elephant shark GR, 
we investigated the evolution of the NTD in chimeras of elephant shark GR and MR, in 
which their NTDs were swapped. 
Overall, we find that the response to corticosteroids by elephant shark GR has 
some similarities and differences with human GR (17, 19, 22, 25), as well as with 
elephant shark MR (36).  In comparison to corticosteroid activation of elephant shark 
MR, corticosteroids have higher EC50s for elephant shark GR, indicating reduced 
sensitivity to corticosteroids [Table 1].  Interestingly, the level of transcriptional 
activation by corticosteroids of elephant shark GR is over 10-fold higher than for 
elephant shark MR (Figure 3A, B).  In this respect, elephant shark GR and MR are 
similar to human GR and human MR in which cortisol has a higher EC50, as well as a 
higher level of transcriptional activation for human GR, compared to human MR (17, 19, 
39). 
Activation of elephant shark GR by aldosterone is a notable difference with 
human GR.  Although 10 nM aldosterone has little activity for human GR (Figure 3A) 
(19, 25), aldosterone and cortisol have a similar level of activation of elephant shark GR.  
Thus, while elephant GR evolved to respond to the physiological glucocorticoids in 
humans and other terrestrial vertebrates, elephant shark GR retains some activities of 
elephant shark MR.  We conclude that elephant shark GR is transitional from the MR in 
specificity for glucocorticoids and mineralocorticoids. 
A novel property of elephant shark MR is that it is activated by progesterone and 
19norProgesterone (36).  Neither steroid activates elephant shark GR.  Unexpectedly, 
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progesterone and 19norProgesterone inhibit activation of elephant shark GR by 
corticosterone (Figure 5A), which suggests that progestins may influence activation of 
elephant shark GR.  Neither progesterone nor 19norProgesterone inhibit activation of 
human GR by cortisol (Figure 5B).  The timing of the loss of recognition of progestins 
by the GR needs further study. 
The deletion of the NTD from elephant shark GR has similar effects on 
corticosteroid activation as found for human GR (17, 24), (Table 1, Figure 3D).  Thus, 
deletion of the NTD in human GR reduces cortisol and dexamethasone activity by over 
90% (17, 24).  Similarly, we find that truncated elephant shark GR loses over 90% of 
activation by corticosteroids compared to full-length elephant shark GR.  In contrast, 
full-length and truncated elephant shark MRs have similar responses to corticosteroids 
(Figures 3 B, D, Table 1). 
Experiments with chimeras in which the NTD of elephant shark GR and MR 
were swapped reveal that the NTD in the GR and MR have a dominant effect on 
transcriptional activation of each chimera.  Replacing the MR NTD with the GR NTD 
increases corticosteroid activation of the GR-NTD MR-LBD chimera compared to 
full-length MR, while activity of MR-NTD GR-LBD chimera is reduced to that of 
full-length MR.  This indicates that NTD stimulation of activation by corticosteroids of 
the GR arose early in vertebrate evolution. 
The evolution of a distinct GR and MR in cartilaginous fish has provided an 
opportunity to investigate early events in the divergence of these two steroid receptors 
from their common ancestor.  Cartilaginous fish, including elephant shark, also contain 
a PR and AR, which diverged from a common ancestor.  The PR is a close relative of 
the MR.  Comparison of steroid activation of elephant shark PR and AR with each 
other and with the MR and GR could provide valuable insights into their evolution as 
important transcription factors in vertebrates. 
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Supplementary Material 
Materials and Methods 
Chemical reagents. Aldosterone, cortisol, corticosterone, 11-deoxycorticosterone, , 
progesterone and 19norProgesterone were purchased from Sigma-Aldrich.  For the 
reporter gene assays, all hormones were dissolved in dimethylsulfoxide (DMSO) and 
the final concentration of DMSO in the culture medium did not exceed 0.1%. 
Construction of plasmid vectors The full-coding regions and DBD-LBD domains of 
the GR and MR from C. milii were amplified by PCR with KOD DNA polymerase 
(TOYOBO Biochemicals, Osaka, Japan).  The PCR products were gel-purified and 
ligated into pcDNA3.1 vector (Invitrogen) (40). 
Transactivation Assay and Statistical Methods. Hek293 were used in the reporter 
gene assay.  Transfection and reporter assays were carried out as described previously 
(40, 41).  All transfections were performed at least three times, employing triplicate 
sample points in each experiment.  The values shown are mean ± SEM from three 
separate experiments.  Data from studies of the effect of different corticosteroid 
concentrations on transcriptional activation of elephant shark GR and MR were used to 
calculate EC50s for steroid activation of elephant shark GR and MR using GraphPad 
Prism.  Comparisons between two groups were performed using t-test, and all 
multi-group comparisons were performed using one-way ANOVA followed by 
Bonferroni test.  P < 0.05 was considered statistically significant. 
Genbank Accessions for Domain Comparison. Elephant shark GR (XP_007899521), 
human GR (BAH02307), chicken GR (ABB05045), X. laevis GR (NP_001081531), 
Zebrafish GR (NP_001018547), elephant shark MR (XP_007902220), human MR 
(NP_000892), zebrafish MR (NP_001093873). 
